FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

33617611000001109: Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Nov 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
101364501000001111 Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
101364601000001110 Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has active ingredient Levothyroxine true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has specific active ingredient Levothyroxine sodium anhydrous true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Is a Levothyroxine sodium 12.5microgram tablets true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has active ingredient Thyroxine false Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has specific active ingredient Levothyroxine sodium anhydrous false Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) 28 tablet 4 x 7 tablets Has AMP True Levothyroxine sodium 12.5microgram tablets (Teva UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start